Baylor Scott & White Health: Clinical Trial Results Published in Nature Medicine Show Immunotherapy's Potential in Resectable Esophageal, Gastroesophageal Junction Cancers
March 20, 2024
March 20, 2024
DALLAS, Texas, March 20 (TNSres) -- Baylor Scott and White Health issued the following news release on March 19, 2024:
The results of a study published today in Nature Medicine show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy. The study results also show the potential for monitoring circulating tumor DNA as a predictor for future intervention.
The article, titled "Neoadjuvant nivolumab o . . .
The results of a study published today in Nature Medicine show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy. The study results also show the potential for monitoring circulating tumor DNA as a predictor for future intervention.
The article, titled "Neoadjuvant nivolumab o . . .